Orion’s statutory co-operation negotiations completed regarding the Research & Development function

NEXT STORY
VitalHub Announces Large-Scale Expansion Licensing Deal and Upgrade to Virtual Care Module with King’s College Hospital NHS Foundation Trust
PREV STORY
MediPharm Labs Initiates Clinical Trial for Use of Cannabis to Treat Chronic Kidney Disease Patients and Improve Quality of Life
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EyeGate Pharma Announces Positive Top-line Data from First-in-Human Pilot Trial of Ocular Bandage Gel in Corneal Epithelial Defects

WALTHAM, Mass., Jan. 30, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or ...

author_avatar
NASDAQ Market News

Ebola Vaccine Regimen from Johnson & Johnson and Bavarian Nordic Supports World Health Organization in Efforts to Prevent Spread of Ebola in West Africa

author_avatar
NASDAQ Market News

Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications

Candidate to expand Zai Lab’s early-stage R&D programs, with an anticipated IND Filing for ...

author_avatar
NASDAQ Market News